Sebastian Oltean
Exeter, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
The insulin/IGF axis is critically important for controlling gene transcription in the podocyte.
Journal: eLife
Published: September 04, 2026
Down-Regulation of Proline Rich Homeodomain/Haematopoietically Expressed Homeobox Expression in Prostate Cells Enables Tumour Initiation and Tumour Growth.
Journal: Cancers
Published: March 30, 2026
Modulators of epithelial-mesenchymal transitions in prostate cancer: potential for novel therapeutics development.
Journal: Frontiers in pharmacology
Published: February 10, 2026
Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model.
Journal: Cancers
Published: October 23, 2025
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular disease.
Journal: American journal of physiology. Heart and circulatory physiology
Published: June 30, 2025
Aberrant Splicing as a Mechanism for Resistance to Cancer Therapies.
Journal: Cancers
Published: February 17, 2025
Splice Isoforms of the Apoptosis Gene BCL-X Have Opposing Effects in Diabetic Kidney Disease: Potential Treatment Target and Prognostic Value.
Journal: Journal of diabetes research
Published: February 11, 2025
Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an EGFR mutation in tissue: a UK pilot study.
Journal: Frontiers in oncology
Published: March 30, 2023
The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor.
Journal: Molecular oncology
Published: June 07, 2021
A repositioning screen using an FGFR2 splicing reporter reveals compounds that regulate epithelial-mesenchymal transitions and inhibit growth of prostate cancer xenografts.
Journal: Molecular therapy. Methods & clinical development
Published: March 10, 2021
A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties.
Journal: Oncogenesis
Published: April 06, 2020
Last Updated: 09/26/2026